Regenexx

Regenexx specializes in innovative non-surgical treatments for orthopedic disorders, focusing on the use of stem cells and blood growth factors to promote the regeneration of bone and cartilage. The company has created a patent-pending procedure and has developed various processing and treatment techniques that aim to reduce orthopedic costs while improving patient outcomes. Regenexx is also recognized for its significant contribution to the research on mesenchymal stem cells, having published a substantial portion of global studies in this area. Through its dedicated network of physicians, Regenexx emphasizes patient education and involvement, encouraging individuals to explore their treatment options actively.